Delivery Order SPE2DB20D3104-SPE2DB22FV9H0
- Not listed
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,561,888,754 units of Atomoxetine HCL 18 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $4,381.89, has a firm fixed price and an ultimate completion date of August 22, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.09 firm fixed-price delivery order is for the provision of 4,563,867,448 units of the medication Atomoxetine HCL 25 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,547.45 firm fixed-price delivery order is for the supply of 4,567,240,539 units of Atomoxetine HCL 40 mg capsules. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.93 firm fixed-price delivery order is for the supply of 4566771107 - Atomoxetine HCL 40 mg capsules in quantities of 30s. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $3,153.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,260 units of Atomoxetine HCL 40 mg capsules. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which supports the procurement of a comprehensive range of pharmaceutical products and medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,095.38 firm fixed-price delivery order is for the supply of 4,565,504,831 units of the prescription medication Atomoxetine HCL 60 mg capsules. The contract has an ultimate completion date of August 20, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $1,690.44 delivery order for the supply of 4557030315 - Atomoxetine HCL 40 MG Capsules. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award is for the delivery of Atomoxetine HCL 25 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,008.04 firm-fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atomoxetine HCL 60 mg capsules. The $1,349.79 Firm Fixed Price delivery order is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,200.15, is for the delivery of 4,565,600,866 units of Atomoxetine Hydrochloride 100 mg capsules. The contract does not have a set-aside designation and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV9H0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,504.30 delivery order is for 4,558,371,656 units of Atomoxetine HCL 40 mg capsules. The award is part of a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/7/22 |